Oral Agents for Treatment of Patients with Advanced Pancreatic Neuroendocrine Tumors: Could Pharmaeconomic, Cost-Effectiveness Data Play a Significant Role?
Maria Elisa Barna, Ilaria Uomo, Maurizio Pastorello
Visit for more related articles at
Select your language of interest to view the total content in your interested language